Literature DB >> 18826055

Amylose affinity chromatography of maltose-binding protein: purification by both native and novel matrix-assisted dialysis refolding methods.

Leonard K Pattenden1, Walter G Thomas.   

Abstract

Maltose-binding protein (MBP) is a carrier protein for high level recombinant protein and peptide production from either the cytoplasm or periplasm of Escherichia coli. The affinity matrix for purifying MBP-passenger proteins utilizes amylose covalently attached to magnetic beads, agarose, or a chemically inert fast protein liquid chromatography (FPLC) matrix--exploiting the natural affinity of MBP for alpha-(1-->4)-maltodextrins in the stationary phase. A fundamental problem is the expression and purification failure of as much as 30% of all constructs, which is limiting for one of the best solubilizing carrier proteins available for recombinant expression. In this chapter, we have discussed aspects of MBP biology that can impact upon binding to the amylose affinity matrix including cloning considerations, structural complications, hydrophobic buffer additives and the presence of cellular biomolecules that bind or modify the matrix during purification. Chromatography conditions are presented for purification at very small scales of less than 0.5 mL using amylose magnetic beads, a batch and semi-batch method for small to moderate scale purifications up to approximately 35 mg and larger scale FPLC methods. A novel matrix-assisted dialysis refolding method is also described whereby MBP-passenger proteins can be refolded in the presence of amylose matrix in instances where native purification methods fail to bind the amylose matrix.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18826055

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  ITEM-THREE analysis of a monoclonal anti-malaria antibody reveals its assembled epitope on the pfMSP119 antigen.

Authors:  Kwabena F M Opuni; Cornelia Koy; Manuela Russ; Maren Reepmeyer; Bright D Danquah; Moritz Weresow; Astrid Alef; Peter Lorenz; Hans-Juergen Thiesen; Michael O Glocker
Journal:  J Biol Chem       Date:  2020-08-26       Impact factor: 5.157

2.  Characterization of human flavin-containing monooxygenase (FMO) 3 and FMO5 expressed as maltose-binding protein fusions.

Authors:  Robert R Reddy; Erik C Ralph; Meike S Motika; Jun Zhang; John R Cashman
Journal:  Drug Metab Dispos       Date:  2010-09-01       Impact factor: 3.922

Review 3.  Overcoming the Solubility Problem in E. coli: Available Approaches for Recombinant Protein Production.

Authors:  Claudia Ortega; Pablo Oppezzo; Agustín Correa
Journal:  Methods Mol Biol       Date:  2022

4.  In-Depth Characterization of a Re-Engineered Cholera Toxin Manufacturing Process Using Growth-Decoupled Production in Escherichia coli.

Authors:  Natalia Danielewicz; Wenyue Dai; Francesca Rosato; Michael E Webb; Gerald Striedner; Winfried Römer; W Bruce Turnbull; Juergen Mairhofer
Journal:  Toxins (Basel)       Date:  2022-06-08       Impact factor: 5.075

5.  Multi-Compartment and Multi-Host Vector Suite for Recombinant Protein Expression and Purification.

Authors:  Claudia Ortega; Daniel Prieto; Cecilia Abreu; Pablo Oppezzo; Agustín Correa
Journal:  Front Microbiol       Date:  2018-06-27       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.